FGFR2 and intrahepatic cholangiocarcinoma: In general, the prognosis of small duct-type ICC is significantly better than that of large duct-type ICC, partly because of favorable prospects for targeted therapy, as genetic alterations in IDH1/2 and FGFR2 are predominantly found in small duct-type ICC [8, 9].